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Abstract
Background
There is continuing public debate about treatment preferences at the end of life, and the
acceptability and legal status of treatments that sustain or end life. However, most surveys
use binary yes/no measures, and little is known about preferences in neurological disease
when decision-making capacity is lost, as most studies focus on cancer. This study investi-
gates changes in public preferences for care towards the end of life, with a focus on mea-
sures to sustain or end life.
Methods
Large-scale international public opinion surveys using a six-stage patient vignette, respon-
dents chose a level of intervention for each stage as health and decision-making capacity
deteriorated. Cross-sectional representative samples of the general public in Great Britain
and the USA (N = 2016). Primary outcome measure: changes in respondents’ preferences
for care, measured on a four-point scale designed before data collection. The scale ranged
from: maintaining life at all costs; to intervention with agreement; to no intervention; to mea-
sures for ending life.
Results
There were no significant differences between GB and USA. Preference for measures to
sustain life at all costs peaked at short-term memory loss (30.2%, n = 610). Respondents
selecting ‘measures to help me die peacefully’ increased from 3.9% to 37.0% as the condi-
tion deteriorated, with the largest increase occurring when decision-making capacity was
lost (10.3% to 23.0%). Predictors of choosing ‘measures to help me die peacefully’ at any
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stage were: previous personal experience (OR = 1.34, p<0.010), and older age (OR = 1.09
per decade, p<0.010). Negative predictors: living with children (OR = 0.72, p<0.010) and
being of “black” race/ethnicity (OR = 0.45, p<0.001).
Conclusions
Public opinion was uniform between GB and USA, but markedly heterogeneous. Despite
contemporaneous capacitous consent providing an essential legal safeguard in most juris-
dictions, there was a high prevalence of preference for “measures to end my life peacefully”
when decision-making capacity was compromised, which increased as dementia pro-
gressed. In contrast, a significant number chose preservation of life at all costs, even in end
stage dementia. It is challenging to respect the longstanding values of people with dementia
concerning either the inviolability of life or personal autonomy, whilst protecting those with-
out decision-making capacity.
Introduction
Decisions about medical treatment for people approaching the end of life raise clinical and eth-
ical challenges. More people living longer with multiple comorbidities, and advancing medical
technologies offering more treatment options, have led to greater complexity in clinical man-
agement and decision-making,[1–3] the more so if the person concerned lacks the capacity to
participate in decisions about their care. As the end of life approaches, patients and clinicians
may need to decide whether to continue life-sustaining treatments and artificial nutrition and
hydration (ANH) which could also prolonging suffering. In some jurisdictions it is permissible
to take active measures to end the patient’s life: physician-assisted dying (PAD) is now permit-
ted in 6 European countries, Canada and 5 US States (Box 1).
Box 1. Assisted-dying and euthanasia legislation dying worldwide
Switzerland 1942 Assisted dying is not legal, but Article 115 of the Swiss Penal Code
permits assisting suicide if the person does so for “unselfish reasons”. Physicians may
prescribe lethal drugs, as long as the recipient takes an active role in drug administration.
Not restricted to Swiss residents.
Japan 1995 There are no acts, laws or statutes on either euthanasia nor assisted dying;
and no prohibitions against it. A court case in 1995, following a death at Tokai Univer-
sity, set out four conditions under which euthanasia may occur: unbearable physical
pain; close to death; patient consent; and exhaustion of all other pain relief treatments
without success.
Oregon (USA) 1997 First jurisdiction to legalise assisted dying. The legislation per-
mits the prescription of lethal drugs to adults with a terminal illness, a life expectancy of
six months or less, and a sound state of mind.
Colombia 1997 In 1997 the Colombian Constitutional Court decriminalised “mercy
homicide”, but the conditions under which it could occur were not outlined until 2015.
Albania 1999 /2002 In 1999, Albania responded to the European Health Committee,
that there were no laws on euthanasia, and thus no legal sanctions against it. Instead phy-
sicians are governed by The Code of Ethics and Medical Deontology (2002 rev. 2012)
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PAD encompasses physician-assisted suicide (PAS) and voluntary euthanasia (VE) (Box 2).
Voluntary euthanasia for people with dementia is now permissible in the Netherlands, for
those who have made Advance Directives requesting it.[4] (Box 2).
which forbids active euthanasia but allows intervention at the physician’s discretion
when patient is unconscious, with no hope to live.
Netherlands 2002 Under Dutch law, any action intended to terminate life is in prin-
ciple a criminal offence. The only exemption from criminal liability is when a patient is
experiencing ‘unbearable suffering’ with no prospect of improvement, and the physician
fulfils the statutory ‘due care’ criteria. Patients may use advance directives to request
euthanasia if they ever suffer from severe dementia. However, this may only be fulfilled
if ‘due care’ is taken and the patient is experiencing unbearable suffering with no pros-
pect of improvement.
Belgium 2002 Voluntary euthanasia by lethal injection is legal for patients who are
mentally competent and have an incurable condition, including mental illness, that
causes them constant and unbearable physical or mental suffering.
Washington (USA) 2008 Legislation broadly similar to Oregon, legalising assisted
dying.
Luxembourg 2009 Euthanasia and assisted suicide legalised for mentally competent
adults with a severe and incurable terminal condition, causing constant and unbearable
physical or psychological suffering without prospects of improvement.
Montana (USA) 2009 A physician may raise a defence of ‘consent’ if charged with
assisting suicide, Baxter v. Montana 2009.
Vermont (USA) 2014 Legislation broadly similar to Oregon, legalising assisted
dying.
California (USA) 2015 Legislation broadly similar to Oregon, legalising assisted
dying.
South Africa 2015 Assisting suicide remains illegal. However, in 2015 a Pretoria
High Court granted a man with terminal cancer an order that would allow a doctor to
assist him in taking his own life without the threat of prosecution.
Germany 2015 The German Bundestag approved assisted suicide for altruistic rea-
sons, in legislation broadly similar to Swiss laws but banned the commercialisation of
assisted suicide.
Canada 2016 Assisting a person with suicide was illegal under section 241(b) of the
Canadian Criminal Code. However, in 2015 the Supreme Court of Canada declared sec-
tion 241(b) invalid and from 2016 physician assisted suicide will be legal for a competent
adult, who clearly consents to the termination of life and who has grievous and irremedi-
able condition.
Box 2. Terminology on assisted dying
Assisted dying. Prescribing life-ending drugs for terminally ill, mentally competent
adults to administer themselves after meeting strict legal safeguards. Defined in this way,
it is legal and regulated in the US states of Oregon, Vermont, and Washington. It is what
the recent Assisted Dying Bill in England and Wales proposed.
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Debate surrounding PAD goes to the heart of clinical ethical principles: beneficence versus
non-maleficence and a patient’s right to autonomy.[5] Critics have argued “physician-assisted
suicide is fundamentally inconsistent with the physician’s professional role”.[6, 7] Conversely,
those who support PAD argue a prolonged death could increase unnecessary physical and psy-
chological suffering, and that patients should have the right to autonomy over their own bod-
ies.[8] Further concerns involve the “slippery slope” and protecting vulnerable persons.[9] The
Oregon and Dutch models incorporate consent and disability criteria as safeguards for the vul-
nerable (Box 3).
Public policy and legislation are designed to guide decision-makers through this complex
landscape. They address potentially competing human rights, such as the right to life and the
right to freedom from degrading treatment. In democratic societies, public opinion is also
important for shaping law and policy.[10, 11] There is limited good quality evidence on public
attitudes concerning issues related to care at the end of life.[12] Despite recent media attention
concerning assisted dying in the UK, USA and Canada, open discussion remains taboo.[13–
16] Previous surveys have found strong UK public support for PAD, repeatedly around 70%,
[17–20] with 63% and 68% of American UK public respectively in 2015.[17, 21]
As part of a programme of research investigating decision-making concerning nutrition
and hydration in progressive neurological diseases associated with varying decision-making
capacity, we developed survey instrument to investigate public opinion concerning ANH in
those circumstances.
Assisted suicide. Giving assistance to die to disabled and other people who are not
dying, in addition to patients with terminal illness. Drugs are self-administered. Defined
in this way, assisted suicide is permitted in Switzerland. Some opponents of the Assisted
Dying Bill in England and Wales do not accept “assisted dying” as distinctly different.
Voluntary euthanasia. Doctor administration of life-ending drugs to a patient who
has given consent. Defined in this way, voluntary euthanasia is permitted in the Nether-
lands and Belgium.
(Source: White, Dyer and Radar, BMJ 2015;351
Box 3. Common safeguards in the Oregon and Dutch models of
Physician Assisted Dying (PAD)
Consent criteria: In most jurisdictions, contemporaneous consent by patients judged to
have the requisite mental capacity forms an important safeguard to ensure that no one is
unjustly deprived of their right to life. In the Netherlands, an Advance Directive (“living
will”) fulfils the consent criterion for patients with dementia, is a notable exception to
the requirement for contemporaneous consent.
Disability criteria: Physician-assisted dying (PAD) in the USA, and Voluntary
Euthanasia (VE) and Physician-assisted Suicide (PAS) in Luxembourg are only legal in
cases of established terminal illness. In the Netherlands and Belgium, VE and PAS are
permitted in cases of ‘unbearable suffering’ even if the patient is not expected to die
within the foreseeable future.
Preferences for care towards the end of life
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Aims
To investigate the preferences of members of the public regarding care, treatment and out-
come, at different stages of illness towards the end of life, as decision-making capacity and
swallowing ability deteriorate due to progressive neurological disease. This paper focuses on
preferences for measures to sustain or to end life.
Methods
Most surveys are limited by employing binary yes/no measures. Vignette design is a nuanced
way of exploring respondents’ values and judgments concerning sensitive subject areas.[22,
23] A six-stage vignette featured a fictitious person living in a care home whose abilities in
both decision-making capacity and swallowing are declining. In the final stage, the person is
bed bound, unable to swallow, spends most of their time asleep and has no capacity to make
decisions about their care. The stages were developed from: the research literature, including
a systematic review of the international literature on ANH;[24] an observational study of a
UK hospital feeding issues team;[25] and the expertise of the research team in decision-mak-
ing capacity, palliative medicine, feeding issues and medical ethics. The instrument was
piloted at research group meetings of academics and clinicians, and was adapted for the lay
public by Ipsos MORI, the external research organisation who undertook the survey field-
work. Ipsos MORI are global research company with specialisms in healthcare, and social
and political research. Minor adaptations were made by Ipsos MORI USA: it became an
online survey and some terminology was changed e.g. “nursing home” substituted for “care
home”.
The dependent variable was changes in care preferences, using a four-point scale: (1) sus-
tain life by using any means necessary, including forced tube insertion for ANH and depriva-
tion of liberty; (2) encourage, but not impose, nutrition and hydration by tube or other
means; (3) no ANH intervention but continuation of oral nutrition and hydration as far as
possible; and (4) provide measures to help die peacefully. Response category 3 broadly
reflected the approach of palliative care. Response category 4 used “provide measures” to
imply intent to end life, while avoiding the potentially emotionally loaded terms of PAS,
PAD and VE: indicating a preference for death to being sustained with nutrition and hydra-
tion, it was designed to allow respondents to interpret the meaning broadly, including PAD,
PAS and VE.
All questions were multiple-choice and closed. Respondents were asked to indicate what
they would want for themselves, regardless of the current law in their jurisdiction. Demo-
graphic information was collected, alongside information concerning previous experience of
these issues. The questionnaire is attached in S1 File.
Fieldwork and recruitment
GB and USA fieldwork and recruitment was undertaken by Ipsos MORI, using previously-
recruited panels paid to complete regular surveys and representative of national populations.
In GB, face-to-face interviews with people aged 15 or over used computer-assisted technology
during January and February 2015. In the USA, an online survey was completed by people
aged 18 or over during July 2015. Respondents were informed that the stages would become
progressively worse and that they were free to refuse to answer any question. To the best of our
knowledge, no survey participants declined to take part in our component of their regular sur-
veys: normal calculations of response rate are not appropriate to public panel surveys of this
nature.
Preferences for care towards the end of life
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Informed consent process
Consent to participate in this survey is a three stage process. Stage (1) when participants are
initially recruited to the Ipsos MORI panel, the interviewer explains; the surveys, the process,
recruitment, anonymity and withdrawal. They then answer any questions the potential respon-
dent has about the survey and the process. As this is happening, the interviewer assesses
whether they are happy that the respondent has the decision-making capacity to proceed with
the survey. If they are in any doubt, they do not proceed. If they are happy, they give the poten-
tial recruit time to consider and then take verbal consent. Once the respondent has verbally
consented, they are asked for their full name (which will not be known by the interviewer until
this point). This is then recorded on the handheld electronic CAPI (Computer Assisted Per-
sonal Interviewing) device to indicate that the respondent has given their informed consent.
For recruitment to the online survey, information about the surveys, the process, recruitment,
anonymity and withdrawal is read by the potential recruit on the computer screen. They are
then given time to consider, and asked to check a box to indicate they have read and under-
stood the information and agree to take part in an online survey. Stage (2) directly before
participating in this questionnaire the respondents are read a statement (or they read it them-
selves on the screen) which describes: the study topic, the objective, funding, who was con-
ducting the study, and how long it would take. The interviewer then checks verbally that the
respondent is happy to proceed, or in the online survey the respondent clicks a box to indicate
they are happy to proceed. Stage (3) The process of informed consent is ongoing in this survey.
Each question has the option to be declined to be answered, if the participant so wishes. The
participant also has the option to withdraw entirely from the survey at any point. For the in-
person survey, the interviewer also continues to monitor the participant to check they do not
look distressed, if they do they interviewer will give the option to stop the survey.
For young adult respondents, aged 15–17 years, parental or guardian consent was taken as
well as the respondent’s own consent. For the US online survey, consent was recorded online
after the respondent had read the anonymity and withdrawal information and the study state-
ment. No persons under age 18 years took part in the US online survey. Ethical approval for
this procedure was obtained from the University of Cambridge Psychology Research Ethics
Committee.
Statistical analysis
Statistical data analysis was undertaken using SPSS version 22 (IBM Corp 2013). Data were
weighted for gender, age, education, ethnicity, work status, and regional area to ensure
national population representativeness (Table 1). Analyses and reported frequencies are based
upon the weighted data set.
The main focus of the analysis presented here is on response categories 1 (sustaining life at
all costs, including using force or deprivation of liberty) and 4 (measures to help die peace-
fully). For these responses we present: (a) descriptive analysis over the 6 patient stages; (b)
differences in the proportions of participants selecting the categories across the 6 stages
(Cochran’s Q test); and (c) differences in proportions of participants selecting the response
categories between two consecutive stages (exact McNemar tests).
Further analysis investigated outlying response groups: those who selected measures to
preserve life at all costs (response 1) in stage 6 (end-stage dementia), which could be consid-
ered contrary to a person’s best interests and; those who selected measures to die peacefully
(response 4) in stages 1, 6 or at any stage. A logistic regression model was fitted to test the rela-
tionship between the likelihood of choosing these response categories and the independent
Preferences for care towards the end of life
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variables of gender, country, ethnicity/race, university education, previous personal experi-
ence, living with children and age in years. Odds ratios are reported.
Results
Survey population
Responses were obtained from 2016 people, 1025 (50.8%) USA and 991 (49.2%) UK.
Unweighted survey data and the estimated representative proportions of UK and USA are
shown in Table 1. Representative sampling methods were used in both countries, but USA
university education was particularly unrepresentative; 41.3% USA sample had a Bachelor’s
degree or higher compared to 29.0% in the US population. Nearly one quarter (23.6%, 476) of
respondents lived in a household with children; 41.5% (836) reported previous experience in a
professional context or with family members or friends.
Missing data
For each stage, respondents could answer “don’t know” or not answer at all. The missing data for
each stage ranged from 1.9% to 2.8%. Combined missing and ‘don’t know’ data are reported.
Response behaviour and patient vignette
Table 2 and Fig 1 summarise responses using weighted data.
Table 1. Unweighted survey population percentages (N = 2016) and estimated percentage national population data.
Great Britain United States
% Survey
Population *1 (N = 991)
% National population *2 % Survey
Population *1 (N = 1025)
% National population *3
Gender
Female 55 51 57 52
Male 45 49 43 48
Age
15/181−24 18 15 12 12
25–34 14 17 14 9
35–44 13 16 16 17
45–54 14 17 23 18
55–64 15 14 21 17
65+ 27 21 16 18
Education
Degree or higher 27 24 41 29
Ethnicity (GB) / Race (US)4
“White” 86 88 81 77
All other groups 14 12 19 23
Notes
* Percentages may not sum to total due to rounding.
1. Great Britain sample includes adults 15 years and over. USA sample includes adults 18 years and over.
2. National Readership Survey Data 2014.
3. US Census 2013 and American Community Survey 2013.
4. The term ‘ethnicity’ was used in Great Britain and ‘race’ in the United States. Ethnic/racial groups were self-defined by respondents using pre-defined
categories.
https://doi.org/10.1371/journal.pone.0172104.t001
Preferences for care towards the end of life
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Maintain life at any cost, including the use of force and restraints even
when resisted
The proportion of respondents choosing this option peaked at 30.2% at Stage 2 (starting to
lose short-term memory), dropped to the lowest point of 13.8% at stage 3 (choking on some
food and drink), then remained largely stable over the last three stages (Fig 2 below).
There was a significant difference in respondents choosing response 1 in all 6 stages (Cochran’s
Q test, p<0.001), with a significant difference in those choosing response 1 across the first three
stages, but not in the last 3 stages (exact McNemar’s tests (p<0.001). The largest increase in those
choosing response 1, from 17.7% to 30.2% occurs between stage 1 (living in a care home, to stage
2 (beginning to lose short term memory). The largest decrease, from 30.2% to 13.8%, occurs
between stage 2 (beginning to lose short term memory) and stage 3 (choking on food and drink).
These changes in proportions choosing response 1 do not differ by country. (S1 Table).
“Measures to help me die peacefully”
The proportions of respondents selecting this option increased significantly between each
stage as the person’s condition deteriorated, from 3.9% to 37.0% (Cochran’s Q test, p<0.001)
and at each stage (exact McNemar’s tests, all p<0.001). The largest increase, 10.3% to 23.0%,
occurred between stages 3 (some memory loss and choking on food), and 4 (very confused
and lost ability to communicate). The second largest increase, 26.6% to 37.0%, occurred
between stages 5 (no decision-making capacity and recent aspiration pneumonia) and 6 (end-
stage disease, bed bound and asleep). This option was selected on at least one occasion by
44.4% (860) of respondents, and never selected by 55.6% (1079) at any stage (excluding miss-
ing cases). (Fig 3 below, S2 Table).
The logistic regression model gave no evidence that gender, country or university education
affected whether respondents chose “measures to help me die peacefully” (p>0.1 for all in S3
Table and Table 3 below). Ethnicity was the strongest predictor, with respondents of “black”
race/ethnicity much less likely than those of “white” race/ethnicity to choose this response
(OR = 0.45). Living in a household with children also reduced the probability of choosing this
response (OR = 0.72), while older participants (OR = 1.09 for each 10-year increase in age)
and those with previous personal experience (OR = 1.34) were more likely to choose this
response. Re-running the analyses including professional experience showed that in contrast
to personal experience, professional experience had no statistically association to the response
behaviour, in the context of the other predictors. (S7, S8, S9 and S10 Tables).
Table 2. Cross-tabulation illustrating total respondents’ answers across the six-stage vignette using weighted data (n = 2016).
Scenario 1
Living in a care
home
Scenario 2
Losing short-
term memory
Scenario 3
Choking on
food and drink
Scenario 4 Very
confused &
capacity loss
Scenario 5
Pneumonia
Scenario 6 End
stage, bed
bound
% n % n % n % n % n % n
Response 1 Sustain life, at any cost 18 357 30 610 14 279 18 358 17 350 17 338
Response 2 Intervention w/ consent 52 1045 34 690 53 1073 35 706 30 601 20 399
Response 3 No intervention 19 380 20 399 11 225 12 248 14 278 14 288
Response 4 Measures for ending life 4 78 7 133 10 208 23 463 27 536 37 745
Don’t know / Refused 8 157 10 184 13 279 12 236 13 251 13 246
Total 100 2016 100 2016 100 2016 100 2016 100 2016 100 2016
Notes.
Weighted data are reported, numbers may not sum to total due to rounding.
https://doi.org/10.1371/journal.pone.0172104.t002
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Outlying groups analysis
Among the heterogeneous responses obtained, three groups were of particular interest. Firstly,
16.8% (337) selected interventions to sustain life at all costs including force and restraints, in
end stage disease. Logistic regression identified age, ethnicity and living with children as signifi-
cant predictors: older participants (OR = 0.78, p<0.001), those living with children (OR = 1.49,
p<0.01) and respondents who identified as “black” (OR = 2.57, p<0.001). (S4 Table).
Secondly, a small proportion of 3.9% (78) chose “measures to help me die peacefully” in the
first stage (living in care home, missing meal times for unknown reasons). Logistic regression
identified only country as a significant predicator for this response behaviour: USA respon-
dents were significantly less likely than GB respondents to select this option (OR = 0.35, p<
.001). (S5 Table).
Fig 1. Percentage of respondents’ end of life preferences across six stages of the vignette scenario (N = 2016).
https://doi.org/10.1371/journal.pone.0172104.g001
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Thirdly, 37.0% (745) chose “measures to help me die peacefully” in end-stage disease. Logis-
tic regression identified ethnicity, experience, age and living with children as significant pre-
dictors: more likely among older participants (OR = 1.11, p<0.001) and those with past
experience (OR = 1.4, p<0.01), and less likely among respondents who did not self-identify as
“white” (OR = 0.26, p<0.001) and those living with children (OR = 0.72, p<0.01). (S6 Table).
Discussion
Heterogeneity of views and the challenge for legislators
This large-scale survey of public opinion found very similar patterns in the views of British
and American respondents. One in six (16.8%) expressed a preference for being tube fed when
Fig 2. Percentage of respondents choosing maintain life at any cost across six stages (N = 2016).
https://doi.org/10.1371/journal.pone.0172104.g002
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the condition had progressed to near the end of life, a stage where the quality of life available
would, to many people, appear minimal. This suggests that a significant minority have a stable
moral intuition that life should be supported, even by invasive medical treatment, regardless of
the family or medical team’s perception of the individual’s quality of life. This is consistent
with a strong, vitalist adherence to the principle of inviolability of human life. On the other
hand, over one third (37%) chose “provide measures to help me die peacefully” as their prefer-
ence for themselves in response to at least one of the stages. This suggests that another, larger,
minority hold the view that death would be preferable to being sustained by ANH in these cir-
cumstances. This option was kept deliberately broad, to include those opting for a non-inter-
ventionist palliative care approach as well as others who would hold that PAD, PAS or VE are
morally permissible and desirable under these circumstances.
Fig 3. Percentage of respondents choosing “measures to help me die peacefully” across six stages (N = 2016).
https://doi.org/10.1371/journal.pone.0172104.g003
Preferences for care towards the end of life
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The challenge for legislators in liberal democracies such as the UK and the US is to enact
legal frameworks that represent the views of the majority without unjustly inhibiting the free-
dom of action of minorities, or putting the lives of people who wish to live at risk.
Valuing life over liberty
A preference for measures to preserve life at all costs, potentially involving deprivation of lib-
erty peaked in response to stage 2. Around 30% of respondents would prefer to be forced to
attend mealtimes, if experiencing short-term memory problems. However, half of these
respondents would not wish this coercion to continue if the condition progressed such that
being fed by mouth would require greater coercion such as the use of physical restraint. These
respondents may be expressing a nuanced moral intuition: generally favouring preservation of
life over respecting individual choice, particularly for potentially vulnerable people, provided
that this can be achieved without resorting to physical force.
Valuing liberty over life
The pattern of respondents’ rejection of deprivation of liberty indicates a widespread moral
intuition that it is wrong to use force to interfere with the apparently autonomous choices of
people with full decision-making capacity. 82% would not want to be made to attend meal-
times if they lived in a care home. However, only around 70% would not want to be forced to
attend meals if they developed short-term memory difficulties, suggesting that the moral
Table 3. Logistic regression for “measures to help me die peacefully” chosen at least once (n = 1834).
Odds Ratio 95% Confidence Interval p-value
Lower Upper
Country 0.439
GB Reference
US 1.08 0.89 1.31
Gender 0.628
Male Reference
Female 0.95 0.79 1.15
University education 0.385
Yes Reference
No 1.10 0.89 1.36
Ethnicity (GB) / Race (US) <0.001
“White” Reference
“Black” 0.45 0.30 0.68
All other groups 0.66 0.48 0.90
Experience <0.010
No Reference
Yes 1.34 1.10 1.62
Living with children <0.010
No Reference
Yes 0.72 0.57 0.90
Age 1.09 1.03 1.15 <0.010
Constant 0.81 0.107
Notes.
Overall model evaluation: Chi square = 68.7, p <0.001.
https://doi.org/10.1371/journal.pone.0172104.t003
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intuition to respect individual choice is tempered when there is some question about the
patient’s ability to appreciate the consequences of their choice, even if their capacity to make
decisions remained sufficiently intact for the law to require that those decisions be respected.
86% of respondents would not want to be forcibly fed if they could no longer safely swallow
ordinary food, higher than at any other stage. This could indicate that, even when there is a
question about a person’s ability to consistently appreciate the consequences of not eating,
there is a widespread intuition that nutrition should not be imposed if this requires the use of
physical force or seems likely to cause distress, even if the potential benefits are considerable.
This is consistent with the principle of ’first do no harm’ in the Hippocratic oath, or ‘non-
maleficence’ in modern medical ethics.[5] The proportion rejecting coercion (force-feeding or
tube-feeding) in response to stages 4–6 remains stable at 82% to 83%. This suggests another
widespread moral intuition: that when people patients have lost the ability to make decisions
for themselves, preservation of life at all costs is not the aim and life-sustaining treatment
should be withheld if the risks and burdens are considered to outweigh the benefits.
Choosing to die
That participants living in households with their children were less likely to choose “measures
to help me die peacefully” is consistent with evidence that dependent children reduces suicide
risk.[26] Participants self- identifying as belonging to black or minority ethnic groups were
also less likely to choose this option, suggesting that moral intuitions regarding care at the end
of life, including the permissibility of VE and PAS, are culturally influenced. This introduces
additional complexity for legislators in multi-cultural societies, particularly where the ethnic
and cultural composition of the legislature or medical profession is different to that of the gen-
eral population.
Two factors increased the likelihood of respondents expressing a preference for “measures
to help me die peacefully”: older age and personal or professional experience of similar illness.
This may indicate generational differences in attitudes to end of life care, including VE and
PAS, and/or that peoples’ views shift as they witness family and friends ageing and dying. It is
of note that in the UK Parliament, the House of Lords (mean age 69 years),[27] voted in favour
of legalising AD in January 2015, but the House of Commons (mean age 50 years)[28] voted
against in September 2015.
Support for the importance of age as a predictor of attitudes towards PAD comes from a
recent cross-sectional survey conducted in the USA in 2015.[29] Periyakoil et al found that
older respondents were significantly more supportive of PAD, and that those who reported
spiritual or religious beliefs were significantly supportive of PAD. Periyakoil et al also, found
that ethnicity and gender were not significant predictors.[29] In contrast, and as discussed
above, the findings from this research revealed ethnicity as a strong predictor of choosing
‘measures to help me die peacefully’. Respondents who self-identified as ‘black’ or non-white
were less likely to select this option. This difference may be because of the narrower geographi-
cal location of respondents in Periyakoil et al (only Hawaii and California) compared with a
representative sample of all US states in this research, or it could be because of the different
descriptions in each survey–something known to affect outcome in studies on PAD.[30] Peri-
yakoil et al focused solely on PAD, were as the survey instrument in this research examined a
broader concept including PAS, PAD and VE.
It appears that most people who would consider death to be preferable to artificially sus-
tained life, including some wishing a form of PAS or VE for themselves, would only prefer this
at a late stage of illness, when the quantity and quality of remaining life is limited. The largest
increases in preference for “measures to help me die peacefully” occurred at stage 4 (person
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loses capacity to make decisions about treatment) and stage 6 (condition progresses to termi-
nal phase).
The ‘Oregon model’ of PAD would not be possible for people in either of those situations.
As well as the capacity criterion not being met at both stages, in stage 4 the disability criterion
(terminal illness) would not be met, while in stage 6, death would be expected to occur natu-
rally within six months, but the person would be unable to self-administer lethal drugs and
their only option for hastening death would be euthanasia.
In jurisdictions that permit PAS or VE, their availability depends upon the wording of the
disability and capacity criteria. People with incurable cancer commonly retain decision-mak-
ing capacity until the late stages: they would have the option of PAD under the Oregon model,
and PAS or VE under the Dutch model. People with progressive neurological diseases such as
multiple sclerosis or motor neurone disease, however, may experience “unbearable suffering”
well in advance of the terminal phase. PAS and VE would be available to them in the Nether-
lands and Belgium, but not the US or Luxembourg. By the terminal phase their physical dis-
abilities would, in all likelihood, prevent them from ending their own life by PAD: VE would
be the only option for hastening death, and would be permitted in Luxembourg but not in the
US. The risk of permitting PAS but not VE for unbearable suffering is that people would have
to choose between using PAS to end their life earlier than they may have wished to or losing
altogether the opportunity to hasten their own death in the terminal phase of illness.
People with dementia experience a long and unpredictable illness course: the relatively
early loss of decision-making capacity would require either the Swiss model of allowing PAS in
early illness, or the Dutch model of Advance Directives. The Swiss approach is not compatible
with the wishes expressed by the 37% of study respondents preferring measures to help them
die in end-stage dementia, but the Dutch approach is.
From a consequentialist perspective, there is no significant difference in the end-stages of
dementia between respecting an Advance Directive to refuse ANH and upholding an Advance
Directive to consent to VE. However, both of these approaches are open to the criticism that,
by allowing a decision to hasten death made in the past, by someone who does not know what
it is like to have dementia, does not extend the reach of self-determination. By privileging that
past decision, there is a risk of hastening the death of someone who may still enjoy a reasonable
quality of life and wants to continue living. Some argue further, that dementia so profoundly
changes personality and sense of self that the person who makes an Advance Directive before
the condition progresses is not the same person as the one whose death is hastened when they
have lost capacity.[31]
An alternative position, that there is a meaningful distinction to be made between (permis-
sible) Advance Directives to refuse ANH and (impermissible) advance consent to VE, is based
upon a moral distinction between acts and omissions. In requiring doctors to respect advance
refusals, the law does not compel doctors to act in ways contrary to their professional obliga-
tion to help and avoid harming patients. Should the law require doctors to respect advance
consent for VE, this would compel a doctor to undertake an act that appears to harm their
patient. Arguably, VE may not be harmful, if this is what the patient wants and if it ends, rather
than causes, suffering. However this is less clear with VE authorised by Advance Directive, as
the person may have changed their mind after developing dementia.
The Oregon model of PAD would permit the provision of help to die for a small number
of people, whilst the disability criterion based on terminal illness and the consent criterion
based on contemporaneous, capacitous consent limit the potential for harm via the ‘practical
slippery-slope’. However, these same safeguards would make help to die unavailable in the sit-
uations where, according to our findings, some people may want it. Potentially, this discrimi-
nates against people with conditions that limit either their physical ability to self-administer
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lethal drugs, or their capacity to consent to PAS or euthanasia when they reach the terminal
phase of illness.
Advance directives provide a potential solution. Advance decisions to refuse ANH are
legally binding, even if ANH is believed to be in the patient’s best interests. The Dutch model
could be adapted to protect the choices of other people who want an approach that their physi-
cian may disagree with, to be delivered after they have lost decision-making capacity, be that
the continuation of ANH or euthanasia.
The limitations of this study are that the survey instrument did not ask people directly
about their religious/spiritual views, which other recent research has shown to be an important
predictive factor.[29] Another limitation is the lack of exploration of the impact of household
income and socioeconomic status of respondents in light of the different healthcare systems in
the USA and GB. Further research could investigate these issues in greater depth.
Conclusions
This survey reveals varied and nuanced views among the US and GB public regarding medical
treatment towards the end of life, including ANH, in incurable progressive conditions. Our
analysis highlights the difficulties inherent in attempting to incorporate these views into legal
regulation of end-of-life care. Current legal frameworks provide stronger protection for those
who wish to refuse ANH near the end of life than for those who would request it. Philosophical
and practical objections to the use of advance decisions in dementia persist.
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